Peijia Medical Yönetim

Yönetim kriter kontrolleri 3/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Yi Zhang

İcra Kurulu Başkanı

CN¥1.5m

Toplam tazminat

CEO maaş yüzdesi50.7%
CEO görev süresi12.5yrs
CEO sahipliği0.8%
Yönetim ortalama görev süresi5.1yrs
Yönetim Kurulu ortalama görev süresi5.1yrs

Son yönetim güncellemeleri

Recent updates

Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 26% Share Price Surge

Sep 09
Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 26% Share Price Surge

Risks Still Elevated At These Prices As Peijia Medical Limited (HKG:9996) Shares Dive 30%

Jul 17
Risks Still Elevated At These Prices As Peijia Medical Limited (HKG:9996) Shares Dive 30%

More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%

Mar 28
More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%

More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 29%

Jan 22
More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 29%

Estimating The Intrinsic Value Of Peijia Medical Limited (HKG:9996)

Dec 05
Estimating The Intrinsic Value Of Peijia Medical Limited (HKG:9996)

Does Peijia Medical (HKG:9996) Have A Healthy Balance Sheet?

Oct 22
Does Peijia Medical (HKG:9996) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Peijia Medical Limited (HKG:9996)

Aug 04
Calculating The Fair Value Of Peijia Medical Limited (HKG:9996)

Is Peijia Medical (HKG:9996) A Risky Investment?

May 29
Is Peijia Medical (HKG:9996) A Risky Investment?

Getting In Cheap On Peijia Medical Limited (HKG:9996) Is Unlikely

May 10
Getting In Cheap On Peijia Medical Limited (HKG:9996) Is Unlikely

Are Investors Undervaluing Peijia Medical Limited (HKG:9996) By 40%?

Jan 17
Are Investors Undervaluing Peijia Medical Limited (HKG:9996) By 40%?

Despite Lacking Profits Peijia Medical (HKG:9996) Seems To Be On Top Of Its Debt

Oct 05
Despite Lacking Profits Peijia Medical (HKG:9996) Seems To Be On Top Of Its Debt

A Look At The Fair Value Of Peijia Medical Limited (HKG:9996)

Aug 29
A Look At The Fair Value Of Peijia Medical Limited (HKG:9996)

We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely

Mar 16
We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely

We Think Peijia Medical (HKG:9996) Can Easily Afford To Drive Business Growth

Nov 26
We Think Peijia Medical (HKG:9996) Can Easily Afford To Drive Business Growth

We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely

Jul 30
We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely

Is Peijia Medical Limited (HKG:9996) Worth HK$28.3 Based On Its Intrinsic Value?

May 05
Is Peijia Medical Limited (HKG:9996) Worth HK$28.3 Based On Its Intrinsic Value?

Could The Peijia Medical Limited (HKG:9996) Ownership Structure Tell Us Something Useful?

Mar 03
Could The Peijia Medical Limited (HKG:9996) Ownership Structure Tell Us Something Useful?

Peijia Medical Limited's (HKG:9996) Intrinsic Value Is Potentially 43% Above Its Share Price

Jan 27
Peijia Medical Limited's (HKG:9996) Intrinsic Value Is Potentially 43% Above Its Share Price

We Think Peijia Medical (HKG:9996) Can Afford To Drive Business Growth

Dec 23
We Think Peijia Medical (HKG:9996) Can Afford To Drive Business Growth

CEO Tazminat Analizi

Yi Zhang'un ücretlendirmesi Peijia Medical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CN¥252m

Mar 31 2024n/an/a

-CN¥322m

Dec 31 2023CN¥1mCN¥740k

-CN¥393m

Sep 30 2023n/an/a

-CN¥460m

Jun 30 2023n/an/a

-CN¥528m

Mar 31 2023n/an/a

-CN¥468m

Dec 31 2022CN¥1mCN¥1m

-CN¥408m

Sep 30 2022n/an/a

-CN¥449m

Jun 30 2022n/an/a

-CN¥491m

Mar 31 2022n/an/a

-CN¥533m

Dec 31 2021CN¥2mCN¥1m

-CN¥574m

Tazminat ve Piyasa: Yi's total compensation ($USD205.86K) is below average for companies of similar size in the Hong Kong market ($USD399.57K).

Tazminat ve Kazançlar: Yi's compensation has increased whilst the company is unprofitable.


CEO

Yi Zhang (56 yo)

12.5yrs

Görev süresi

CN¥1,460,000

Tazminat

Dr. Yi Zhang has been an Executive Director of Peijia Medical Limited since May 30, 2012. He serves as the Chairman and Chief Executive Officer at Peijia Medical Limited and served as its Chief Technology...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Yi Zhang
Chairman & CEOno dataCN¥1.46m0.80%
HK$ 20.0m
Leo Tsai
Chief Financial Officer5.6yrsVeri yokVeri yok
Kongrong Pan
Chief Operating Officer7.3yrsVeri yokVeri yok
Fong Tan Jian
Chief Technology Officer3.8yrsVeri yokVeri yok
Ping Ye Zhang
Executive Director4.8yrsCN¥182.00k0.16%
HK$ 3.9m
Hong Ye
Executive Director & Company Secretary12.1yrsCN¥1.36m2.09%
HK$ 52.3m
Xiaoxiao Zhuang
Vice President of Sales4.6yrsVeri yokVeri yok
Hongpeng Wang
Vice President of Marketing5.3yrsVeri yokVeri yok
Hing Ling Chau
Company Secretary2.4yrsVeri yokVeri yok

5.1yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim: 9996's management team is seasoned and experienced (5.1 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Yi Zhang
Chairman & CEO12.5yrsCN¥1.46m0.80%
HK$ 20.0m
Ping Ye Zhang
Executive Director6.3yrsCN¥182.00k0.16%
HK$ 3.9m
Hong Ye
Executive Director & Company Secretary12.1yrsCN¥1.36m2.09%
HK$ 52.3m
Stephen Newman Oesterle
Independent Non-Executive Director4.8yrsCN¥1.55mVeri yok
Huacheng Wei
Independent Non-Executive Director3.2yrsCN¥315.00kVeri yok
Wai Ming Yip
Independent Non-Executive Director4.8yrsCN¥314.00kVeri yok
Fei Chen
Non-Executive Director5.4yrsVeri yokVeri yok
Robert Parks
Independent Non-Executive Director4.8yrsCN¥1.55mVeri yok
Zhiyun Yu
Non-Executive Director8.7yrsVeri yokVeri yok
Jifeng Guan
Non-Executive Director5.1yrsVeri yokVeri yok
Jun Yang
Non-Executive Director4.3yrsVeri yokVeri yok

5.1yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 9996's board of directors are considered experienced (5.1 years average tenure).